Acute Respiratory Infection Unveiling CPT II Deficiency

Int J Mol Sci. 2018 Sep 27;19(10):2950. doi: 10.3390/ijms19102950.

Abstract

Carnitine Palmitoyl transferase 2 (CPT II) is involved in long-chain fatty-acid mitochondrial transport. Three clinical phenotypes of CPT II deficiency have been described: Lethal neonatal onset, infantile severe form, and the late onset more common muscular form. The muscular form of CPT II deficiency is characterized by pain crises and rhabdomyolysis triggered by energy-dependent factors. This form has been described as a benign condition; however, the acute crises are insidious and thus, pose a risk of death. We report a 3-year-old female child with an acute pulmonary infection and a concomitant rhabdomyolysis. The acylcarnitine profile was consistent with CPT II deficiency and a molecular study allowed the identification of the common missense variant (NM_000098.2: c.338C>T ⁻ p. Ser113Leu) at the homozygous state. The striking difference between the initial cause and the decompensation severity prompted us to consider other diagnoses. Deciphering the symptoms linked to CPT II deficiency among those of the initial decompensation results in initiating a timely a targeted therapy.

Keywords: CPT II; acute infection; beta oxidation; carnitine palmitoyl transferase; energy failure; rhabdomyolysis.

Publication types

  • Case Reports

MeSH terms

  • Carnitine O-Palmitoyltransferase / deficiency*
  • Carnitine O-Palmitoyltransferase / genetics
  • Child, Preschool
  • Diagnosis, Differential
  • Female
  • Genetic Testing
  • Humans
  • Metabolism, Inborn Errors / complications
  • Metabolism, Inborn Errors / diagnosis*
  • Metabolism, Inborn Errors / genetics
  • Pneumonia / complications
  • Pneumonia / diagnosis*
  • Rhabdomyolysis / complications
  • Rhabdomyolysis / diagnosis*

Substances

  • Carnitine O-Palmitoyltransferase

Supplementary concepts

  • Carnitine palmitoyl transferase 2 deficiency